Carr Patricia's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Mar 11, 2025
- Accession no.
- 0001765581-25-000031
- Filed
- Mar 11, 2025
- Trade date
- Mar 7-10, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $157.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carr PatriciaCIK 0001784606 | Officer (SVP, Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | Ordinary Shares | DReturned to the companyDisposed | −1,333 | $138.23 | −$184,260.59 | 8,152 | Direct | |
| Mar 10, 2025 | Ordinary Shares | SSaleDisposed | −1,140 | $137.81 | −$157,103.4 | 7,012 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.